Evaluation of recombinant human prourokinase in the treatment of acute pulmonary embolism (ERUPTE): a randomized single-blinded multicenter phase 2 trial

June 23, 2024 | Zhi-Cheng Jing, M.D.; Guangdong Provincial People's Hospital; Guangzhou, China; and Chun-Yan Cheng, M.D., Ph.D.; Guangdong Provincial People's Hospital; Guangzhou, China
RSS
First34568101112Last